High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US9677112B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9677112-B2 |
| Application number | US-201314401775-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 15, 2013 |
| Priority date | May 15, 2012 |
| Publication date | Jun 13, 2017 |
| Grant date | Jun 13, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
β-Lactamase substrates and methods for using the substrates to detect β-lactamase diagnose tuberculosis.
Opening claim text (preview).
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A compound having the formula: or an ester or a salt thereof, wherein A is selected from the group consisting of: (a) substituted and unsubstituted C6-C10 aryl; and (b) substituted and unsubstituted C3-C7 heteroaryl; R 1 is selected from the group consisting of: (a) methoxy; and (b) ethoxy; R 2 is selected from the group consisting of hydrogen, C1-C3 alkyl, C1-C3 alkyl substituted with one or more halogens, and substituted piperazine; X is O or S; R a , R b , R c , and R d are independently selected from the group consisting of hydrogen, halogen, nitro, C1-C3 alkyl, and C1-C3 alkyl substituted with one or more halogens; Z is a moiety that provides a fluorescent, luminescent, or colorimetric signal when released from the compound; and n is 0 or 1. 2. The compound of claim 1 , wherein A is phenyl. 3. The compound of claim 1 , wherein R 1 is methoxy. 4. The compound of claim 1 , wherein X is O. 5. The compound of claim 1 , wherein n is 0. 6. The compound of claim 1 , wherein n is 1. 7. The compound of claim 1 , wherein Z is a fluorescent moiety. 8. The compound of claim 1 , wherein Z is a fluorescent phenolic dye moiety. 9. The compound of claim 1 , wherein Z is selected from the group consisting of a courmarin moiety, a xanthene moiety, a resorufin moiety, a cyanine moiety, a difluoroboradiazaindacene moiety, a bimane moiety, an acridine moiety, an isoindole moiety, a dansyl moiety, an aminophthalic hydrazide moiety, an aminophthalimide moiety, an aminonaphthalimide moiety, a quinine moiety, a dicyanovinyl moiety, a tricyanovinyl moiety, an indolaniline moiety, an indamine moiety, and derivatives thereof. 10. The compound of claim 1 , wherein Z is a xanthene moiety selected from the group consisting of a fluorescein moiety, a rhodol moiety, a rhodamine moiety, and derivatives thereof. 11. The compound of claim 1 , wherein Z is 12. The compound of claim 1 , wherein Z is wherein R′ is hydrogen or aryl. 13. The compound of claim 12 , wherein R′ is phenyl or substituted phenyl. 14. The compound of claim 1 , wherein Z is 15. A compound of claim 1 having the formula: or an ester or a salt thereof, wherein R 1 is methoxy. 16. A method for detecting beta-lactamase in a sample, comprising: (a) contacting a sample with a compound of claim 1 ; and (b) measuring an optical signal generated from contacting the sample with the compound. 17. A method for diagnosing tuberculosis, comprising: (a) contacting a sample with a compound of claim 1 ; and (b) measuring an optical signal generated from contacting the sample with the compound. 18. The method of claim 17 , wherein the sample is sputum, pleural fluid, spinal fluid, blood, urine, saliva, stool, tissue biopsies, tissue homogenates, directly in live animals or human patients, or a sample obtained by swabbing an area of interest on a subject. 19. The method of claim 17 , wherein the sample comprises a pathogenic bacterial species selected from Bacteroides, Clostridium, Streptococcus, Staphylococcus, Pseudomonas, Haemophilus, Legionella, Mycobacterium, Escherichia, Salmonella, Shigella , or Listeria. 20. The method of claim 17 , wherein measuring an optical signal comprises measuring fluorescence emission intensity. 21. The method of claim 17 , wherein measuring an optical signal comprises measuring absorbance intensity. 22. The method of claim 17 , wherein measuring an optical signal comprises measuring luminescence emission intensity.
Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group · CPC title
involving hydrolase · CPC title
with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3 · CPC title
with the 7-amino-radical acylated by an araliphatic carboxylic acid · CPC title
for tuberculosis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.